Improving sleep isn’t enough: researchers highlight daytime function as key to assessing insomnia treatments
Peer-Reviewed Publication
Updates every hour. Last Updated: 27-Jun-2026 17:16 ET (27-Jun-2026 21:16 GMT/UTC)
About one in nine adults suffer from chronic insomnia and its residual effects like drowsiness, cognitive issues, and irritability as well as increased health risks like diabetes and heart risks if left untreated. While many treatments are available, the challenge lies in determining how well a medication or other sleep aid works in individual patients. Now a new study from the University of Maryland School of Medicine has found using real-time smartphone-based assessments can help to determine the effectiveness of sleep medications by detecting improvements in daytime insomnia symptoms including thinking, fatigue, and mood. Following a two-week course of treatment, this smartphone-based assessment approach detected treatment effects more powerfully than did traditional methods like recall questionnaires.
Food-based interventions to support healthy dietary patterns span a continuum from health promotion to disease prevention, treatment, and reversal with variations in intensity and therapeutic dosing.
IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young adults under the age of 50. It is a refractory brain cancer that is difficult to treat due to its high recurrence rate. Until now, treatment has focused primarily on removing the visible tumor mass. However, a Korean research team has discovered for the first time that normal brain cells acquire the initial IDH mutation and spread out through the cortex long before a visible tumor mass harboring additional cancer mutations forms, opening a new path for early diagnosis and treatment to suppress recurrence.
The human brain is not a fast-healing organ. Normally it doesn’t need to be as adult brain cells are stable and last for a lifetime. When trauma or disease such as a stroke occurs, the brain struggles to bounce back because it has a limited ability to regenerate lost cells.
Stem cell therapy is a promising method for boosting regeneration in the brain, but transplanted cells have struggled to replace damaged tissue and reestablish broken circuits. In a new study of a therapy derived from human stem cells and transplanted into mice, the cells matured, integrated into existing circuits and restored function. By tracing the cells and sequencing their gene expression patterns, the researchers also revealed how transplanted cells find where they need to go and form connections with the nervous system.